Search

Search Results
Results 351 - 360 of 612 for Skin Cancer
  • Salazopyrin
    Drug - 30 Mar 2023
    Consumer Medicine Information (CMI) about Salazopyrin intended for persons living in Australia.
  • Rydapt
    Drug - 20 Feb 2023
    Consumer Medicine Information (CMI) about Rydapt intended for persons living in Australia.
  • Solian
    Drug - 16 Feb 2023
    Consumer Medicine Information (CMI) about Solian intended for persons living in Australia.
  • Duoplidogrel
    Drug - 7 Feb 2023
    Consumer Medicine Information (CMI) about Duoplidogrel intended for persons living in Australia.
  • DuoCover
    Drug - 7 Feb 2023
    Consumer Medicine Information (CMI) about DuoCover intended for persons living in Australia.
  • Clopidogrel Winthrop Plus Aspirin
    Drug - 7 Feb 2023
    Consumer Medicine Information (CMI) about Clopidogrel Winthrop Plus Aspirin intended for persons living in Australia.
  • APX-Clopidogrel/Aspirin 75/100
    Drug - 7 Feb 2023
    Consumer Medicine Information (CMI) about APX-Clopidogrel/Aspirin 75/100 intended for persons living in Australia.
  • Adenuric tablets
    Drug - 7 Nov 2022
    Consumer Medicine Information (CMI) about Adenuric tablets intended for persons living in Australia.
  • Benlysta
    Drug - 12 Oct 2022
    Consumer Medicine Information (CMI) about Benlysta intended for persons living in Australia.
  • Rixadone
    Drug - 8 Sep 2022
    Consumer Medicine Information (CMI) about Rixadone (risperidone) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback